Cargando…
Cadherin 13 Inhibits Pancreatic Cancer Progression and Epithelial-mesenchymal Transition by Wnt/β-Catenin Signaling
Cadherin 13 (CDH13) is an atypical cadherin that exerts tumor-suppressive effects on cancers derived from epithelial cells. Although the CDH13 promoter is frequently hypermethylated in pancreatic cancer (PC), the direct impact of CDH13 on PC is unknown. Accordingly, the expression of CDH13 in PC cel...
Autores principales: | Xu, Dengfei, Yuan, Hui, Meng, Zihong, Yang, Chunmei, Li, Zefang, Li, Mengge, Zhang, Zhigang, Gan, Yu, Tu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052920/ https://www.ncbi.nlm.nih.gov/pubmed/32127937 http://dx.doi.org/10.7150/jca.37762 |
Ejemplares similares
-
A Positive Role of Cadherin in Wnt/β-Catenin Signalling during Epithelial-Mesenchymal Transition
por: Howard, Sara, et al.
Publicado: (2011) -
MicroRNA‐148a‐3p suppresses epithelial‐to‐mesenchymal transition and stemness properties via Wnt1‐mediated Wnt/β‐catenin pathway in pancreatic cancer
por: Fu, Xiaowei, et al.
Publicado: (2020) -
Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial–mesenchymal transition
por: Zhang, Li, et al.
Publicado: (2017) -
Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2020) -
Silencing of RIPK4 inhibits epithelial-mesenchymal transition by inactivating the Wnt/β-catenin signaling pathway in osteosarcoma
por: Yi, Zhigang, et al.
Publicado: (2022)